Tuhura Biosciences Stock Fundamentals
| HURA Stock | 5.54 1.02 15.55% |
TuHURA Biosciences fundamentals help investors to digest information that contributes to TuHURA Biosciences' financial success or failures. It also enables traders to predict the movement of TuHURA Stock. The fundamental analysis module provides a way to measure TuHURA Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TuHURA Biosciences stock.
At present, TuHURA Biosciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 470.3 K, whereas Interest Expense is forecasted to decline to about 17.8 K. TuHURA | Select Account or Indicator |
TuHURA Biosciences Company Number Of Shares Shorted Analysis
TuHURA Biosciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current TuHURA Biosciences Number Of Shares Shorted | 137.52 K |
Most of TuHURA Biosciences' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TuHURA Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, TuHURA Biosciences has 137.52 K of outstending shares currently sold short by investors. This is 95.7% lower than that of the Healthcare sector and 97.3% lower than that of the Biotechnology industry. The number of shares shorted for all United States stocks is 97.08% higher than that of the company.
TuHURA Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TuHURA Biosciences's current stock value. Our valuation model uses many indicators to compare TuHURA Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TuHURA Biosciences competition to find correlations between indicators driving TuHURA Biosciences's intrinsic value. More Info.TuHURA Biosciences is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in shares outstanding category among its peers creating about 0.09 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for TuHURA Biosciences is roughly 10.83 . The current year's Common Stock Shares Outstanding is expected to grow to about 71.4 M. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TuHURA Biosciences' earnings, one of the primary drivers of an investment's value.TuHURA Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TuHURA Biosciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TuHURA Biosciences could also be used in its relative valuation, which is a method of valuing TuHURA Biosciences by comparing valuation metrics of similar companies.TuHURA Biosciences is currently under evaluation in number of shares shorted category among its peers.
TuHURA Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of TuHURA Biosciences from analyzing TuHURA Biosciences' financial statements. These drivers represent accounts that assess TuHURA Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TuHURA Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 498.7M | 115.3M | 2.1B | 390.7M | 351.6M | 587.5M | |
| Enterprise Value | 492.7M | 111.6M | 2.0B | 376.5M | 338.9M | 321.9M |
TuHURA Fundamentals
| Current Valuation | 281.53 M | ||||
| Shares Outstanding | 26 M | ||||
| Number Of Shares Shorted | 137.52 K | ||||
| Price To Book | 195.89 X | ||||
| EBITDA | (29.12 M) | ||||
| Net Income | (29.32 M) | ||||
| Total Debt | 2.34 M | ||||
| Cash Flow From Operations | (7.18 M) | ||||
| Target Price | 15.0 | ||||
| Market Capitalization | 141.65 M | ||||
| Total Asset | 4.36 M | ||||
| Retained Earnings | (88.47 M) | ||||
| Working Capital | 562.42 K | ||||
| Net Asset | 4.36 M |
About TuHURA Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TuHURA Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TuHURA Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TuHURA Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 28.8 K | 25.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out TuHURA Biosciences Piotroski F Score and TuHURA Biosciences Altman Z Score analysis. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.